Annual Review

Overview

The report highlights Galderma's strong 2022 performance, including 13.9% net sales growth and net sales of 3,760 M USD. It describes major product launches, clinical milestones and expanded manufacturing capacity across its dermatology portfolio. ESG highlights include women representing 56% of the global workforce, more than 60% lower greenhouse gas emission intensity and more than 30% lower water consumption intensity since 2010. The report also describes an executive-level ESG Council chaired by the CEO.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2022
Language: English
Pages
File size

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services